Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life-Reference-Cited by-同舟云学术

Clinical Characteristics of Patients with Gastroesophageal Reflux Disease Refractory to Proton Pump Inhibitors and the Effects of Switching to 20 mg Esomeprazole on Reflux Symptoms and Quality of Life

Published:2015-12-31 Issue: Volume:21 Page:4111-4121
ISSN:1643-3750
Container-title:Medical Science Monitor
language:en
Short-container-title:Med Sci Monit

Author:

Takeshima Fuminao¹,Hashiguchi Keiichi¹,Onitsuka Yasunori²,Tanigawa Ken³,Minami Hitomi⁴,Matsushima Kayoko¹,Akazawa Yuko¹,Shiozawa Ken⁴,Yamaguchi Naoyuki¹,Taura Naota¹,Ohnita Ken¹,Ichikawa Tatsuki⁴,Isomoto Hajime¹,Nakao Kazuhiko¹

Affiliation:

1. Department of Gastroenterology and Hepatology, Nagasaki University Hospital, Nagasaki, Japan

2. Department of Internal Medicine, Onitsuka Clinic of Internal Medicine, Nagasaki, Japan

3. Department of Gastroenterology and Hepatology, Tanigawa Clinic of Radiology and Gastroenterology, Nagasaki, Japan

4. 0

Publisher

International Scientific Information, Inc.

Subject

General Medicine

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thailand guideline 2020 for medical management of gastroesophageal reflux disease;Journal of Gastroenterology and Hepatology;2022-01-25

2. Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms;Gastroenterology;2020-04

3. Detection of minimal mucosal esophageal lesions in non-erosive gastroesophageal reflux disease using optical enhancement plus optical magnification;Endoscopy International Open;2019-07-24

4. Esophageal Body Motility for Clinical Assessment in Patients with Refractory Gastroesophageal Reflux Symptoms;Journal of Neurogastroenterology and Motility;2017-01-30

5. Role of altered esophageal intraluminal baseline impedance levels in patients with gatroesophageal reflux disease refractory to proton pump inhibitors;Medicine;2016-08